RIBOZYME-ACTIVATED RNA CONSTRUCTS AND USES THEREOF

RIBOZYMES

APTAMER AND RIBOZYME EQUILIBRIUM SHIFTING (ARES) RNA CIRCUITS AND USES THEREOF

ENHANCED HAMMERHEAD RIBOZYMES AND METHODS OF USE

METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF

POLYNUCLEOTIDES FOR MODIFYING ORGANISMS

COMPOSITIONS AND METHODS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA

RIBOZYME-ENHANCED RNA TRANS-SPLICING

COMPOSITIONS AND METHODS TO RESTORE PATERNAL UBE3A GENE EXPRESSION IN HUMAN ANGELMAN SYNDROME

METHOD FOR DELIVERING RNA TO NEURONS TO TREAT HERPES INFECTIONS

COMPOSITIONS AND METHODS FOR PRODUCTION OF CIRCULAR NUCLEIC ACID MOLECULES

NUCLEIC ACID-CONTROLLED CATALYTIC RNAS FOR TRIGGER-RESPONSIVE REGULATION

RAPID ASSEMBLY OF MULTIPLEX GRNA ARRAYS

CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIONS

CRISPR/CAS SYSTEM AND METHOD FOR GENOME EDITING AND MODULATING TRANSCRIPTION

RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF

CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF

Methods and compositions for transducing lymphocytes and regulating the activity thereof

EFFICIENT RNA SWITCHES AND RELATED EXPRESSION SYSTEMS

METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF

REGULATION OF GENE EXPRESSION VIA APTAMER-MEDIATED CONTROL OF SELF-CLEAVING RIBOZYMES

Ribozyme-mediated RNA Assembly and Expression

Method for delivering RNA to neurons to treat herpes infections

METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF

Compositions and methods to restore paternal UBE3A gene expression in human Angelman syndrome

VIRAL DELIVERY OF RNA UTILIZING SELF-CLEAVING RIBOZYMES AND CRISPR-BASED APPLICATIONS THEREOF

Compositions and methods for treatment of dominant retinitis pigmentosa

PLANT GENOME EDITING

A YEAST TWO-HYBRID RNA-PROTEIN INTERACTION SYSTEM BASED ON CATALYTICALLY INACTIVATED CRISPR-DCAS9

CRISPR/Cas system and method for genome editing and modulating transcription

SYNTHETIC HAMMERHEAD RIBOZYMES WITH LIGAND-RESPONSIVE TERTIARY INTERACTIONS

COMPOSITIONS AND METHODS FOR REGULATION OF GENE EXPRESSION WITH, AND DETECTION OF, FOLINIC ACID AND FOLATES

GENETIC TARGETING IN NON-CONVENTIONAL YEAST USING AN RNA-GUIDED ENDONUCLEASE

Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation

Viral delivery of RNA utilizing self-cleaving ribozymes and CRISPR-based applications thereof

CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIONS

Methods for RNA promoter identification

Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes

Method for delivering RNA to neurons to treat herpes infections

RNA cleavage-induced transcript stabilizer and uses thereof

Argonaute protein-double stranded RNA complexes and uses related thereto

Compositions and methods for regulation of gene expression with, and detection of, folinic acid and folates

Synthetic hammerhead ribozymes with ligand-responsive tertiary interactions

ALKB -FACILITATED RNA METHYLATION SEQUENCING (ARM-SEQ)

Methods for RNA promoter identification

Catalytic strands of minimal hammerhead ribozymes and methods of using the same

Compositions and methods using capsids resistant to hydrolases

Methods and compositions for transducing lymphocytes and regulating the activity thereof

Molecular targets for healing or treating wounds

Compositions and methods using capsids resistant to hydrolases

HAMMERHEAD RIBOZYMES

Process for purifying VLPs

cDNA construct of Salmonidae alphavirus

Ribozyme for identifying modification on RNA sequence and RNA cleavage method using same

Use of ribozymes in the detection of adventitious agents

MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS

Modular aptamer-regulated ribozymes

Compositions and methods for therapy of macular degeneration

Vector utilizing borna disease virus and use thereof

PHARMACEUTICAL COMPOSITION FOR TREATING ADVERSE REACTIONS DUE TO ADMINISTRATION OF SPIEGELMERS

PROCESS FOR THE PREPARATION OF A COMPOSITION OF GENETICALLY MODIFIED HEMATOPOIETIC PROGENITOR CELLS

MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM

CDNA CONSTRUCT OF SALMONIDAE ALPHAVIRUS

Nucleolar targeting of therapeutics against HIV

Modular aptamer-regulated ribozymes

Antisense Oligonucleotides Against VR1

Ribozyme to cleave coronavirus gene

RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)

Use of ribozymes in the detection of adventitious agents

RNA INTERFERENCE COMPOSITIONS AND METHODS

Multivalent rna nanoparticles for delivery of active agents to a cell

ALLELE SUPPRESSION

Nucleolar targeting of therapeutics against HIV

2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid

SUPPRESSION OF POLYMORPHIC ALLELES

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

Herpesvirus ribozymes and vectors

RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

Biosensors based on directed assembly of particles

cDNA construct of salmonidae alphavirus

ANTI-HEPATITIS B VIRUS RIBOZYMAL NUCLEIC ACID

pRNA chimera

Circular DNA vectors for synthesis of RNA and DNA

Self-Processing Rna Expression Cassette

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Use of Ribozymes in the Detection of Adventitious Agents

pRNA chimera

Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells

Polycationic compositions for cellular delivery of polynucleotides

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

Activatable Ribozymal Purification Constructs and Methods of Use

Nucleic Acid Molecules As Herpanase Potent Inhibitors, Compositions And Methods Of Use Thereof

Antisense IAP nucleobase oligomers and uses thereof

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

Antisense IAP nucleobase oligomers and uses thereof

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

Rab9a, rab11a, and modulators thereof related to infectious disease

Antisense IAP nucleobase oligomers and uses thereof

Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)

Antisense IAP nucleobase oligomers and uses thereof

Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies

Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs

RNA interference compositions and methods

Adeno-associated virus-delivered ribozyme compositions and methods of use

Synthesis, deprotection, analysis & purification of RNA & ribozymes

Paramyxovirus vector encoding ribozyme and utilization thereof

Antisense oligonucleotides targeting folate receptor alpha, and the use thereof

Ribozyme therapy for the treatment of proliferative skin and eye diseases

Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR

2'-deoxy-2'alkylnucleotide containing nucleic acid

RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)

Genetic suppression and replacement

RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA)

Hammerhead ribozymes

Desmoglein 4 is a novel gene involved in hair growth

Nucleic acid enzyme light-up sensor utilizing invasive DNA

Methods and materials for treating human papillomavirus infections

RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA

Regulation of transcription with a cis-acting ribozyme

RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)

Use of immunomodulating agents

Identification and use of effectors and allosteric molecules for the alteration of gene expression

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)

Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor

Aptamer constructs

Polycationic compositions for cellular delivery of polynucleotides

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)

Polymearase III-based expression of therapeutic RNAs

RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)

Bioreactive allosteric polynucleotides

RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)

Sp1 and Sp3 targeted cancer therapies and therapeutics

Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases

Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Enzymatic nucleic acids containing 5'-and/or 3'-cap structures

Process for the preparation of a composition of genetically modified hematopoietic progenitor cells

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)

Uses of DNA-PK

Delivery construct for antisense nucleic acids and methods of use